|
SH3KBP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.991000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.268630E-01 |
| Normal-vs-Stage2 |
9.829400E-01 |
| Normal-vs-Stage3 |
2.122600E-01 |
| Normal-vs-Stage4 |
4.298800E-01 |
| Stage1-vs-Stage2 |
3.849200E-01 |
| Stage1-vs-Stage3 |
5.008200E-02 |
| Stage1-vs-Stage4 |
8.699400E-01 |
| Stage2-vs-Stage3 |
3.192800E-01 |
| Stage2-vs-Stage4 |
5.104400E-01 |
| Stage3-vs-Stage4 |
1.978580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.014220E-01 |
| Normal-vs-AfricanAmerican |
6.454000E-01 |
| Normal-vs-Asian |
5.356200E-01 |
| Caucasian-vs-AfricanAmerican |
1.177960E-01 |
| Caucasian-vs-Asian |
3.134800E-01 |
| AfricanAmerican-vs-Asian |
8.855200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.930370E-02 |
| Normal-vs-Female |
1.031800E-01 |
| Male-vs-Female |
7.381800E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.336800E-01 |
| Normal-vs-Extreme_Weight |
2.291600E-02 |
| Normal-vs-Obese |
7.070600E-01 |
| Normal-vs-Extreme_Obese |
7.896800E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.395200E-01 |
| Normal_Weight-vs-Obese |
6.333800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.765800E-01 |
| Extreme_Weight-vs-Obese |
1.944450E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.746400E-01 |
| Obese-vs-Extreme_Obese |
6.166000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.008400E-02 |
| Normal-vs-Age(41-60Yrs) |
9.186200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.457910E-02 |
| Normal-vs-Age(81-100Yrs) |
3.630100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.220300E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.263700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.138700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.284900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.417350E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.851400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.376800E-03 |
| Normal-VS-Type2 PRCC |
9.264000E-01 |
| Normal-VS-KIRP CIMP |
1.764340E-03 |
| Normal-VS-Unclassified PRCC |
1.382610E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.085720E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.422500E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
4.163200E-04 |
| Type2 PRCC-VS-KIRP CIMP |
5.52889999999584E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
1.678150E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.003120E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.614400E-01 |
| Normal-vs-N1 |
6.024100E-02 |
| Normal-vs-N2 |
1.326650E-01 |
| N0-vs-N1 |
2.435700E-02 |
| N0-vs-N2 |
2.594600E-01 |
| N1-vs-N2 |
9.574400E-01 |
|
|
